Hi, what are you looking for?
TheStreet.com analyst Herb Geenberg said that the plethora of restaurant IPOs are giving investors indigestion. What is to blame are hyped-up themes that...
– The generic drug company’s fourth quarter results beat analysts’ estimates. Perrigo Company (NYSE:PRGO; TASE:PRGO) released its fourth quarter and full year results today....
The shooting of Ezell Ford is turning into a high-profile civil rights lawsuit against the Los Angeles Police Department. Steven Lerman, the lawyer for...
Lifeshift Consultancy have announced their endorsement of another new product - KADERMIN, launched by Nutresco - for diabetic and varied cutaneous infections.
Lifeshift Consultancy have announced their endorsement of another new product - KADERMIN, launched by Nutresco - for diabetic and varied cutaneous infections.
Lifeshift Consultancy have announced their endorsement of another new product - KADERMIN, launched by Nutresco - for diabetic and varied cutaneous infections.
– John Paulson’s fund, Paulson & Company, is down along with stocks in July. Paulson Partners saw a 1.3% loss brought about by the...
– New findings published today in the journal Cancer Research reveal that some postmenopausal overweight breast cancer patients who use common anti-inflammatory drugs like...
– A “Trojan horse” treatment for an aggressive form of brain cancer, which involves using tiny nanoparticles of gold to kill tumour cells, has...
– New research published in the September issue of the British Journal of Nutrition and featured in the just released Global Phytonutrient Report highlights...